Takara Bio Management
Management criteria checks 2/4
Takara Bio's CEO is Tsuyoshi Miyamura, appointed in Jun 2014, has a tenure of 11.33 years. directly owns 0.011% of the company’s shares, worth ¥13.15M. The average tenure of the management team and the board of directors is 3.8 years and 7.8 years respectively.
Key information
Tsuyoshi Miyamura
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 11.3yrs |
| CEO ownership | 0.01% |
| Management average tenure | 3.8yrs |
| Board average tenure | 7.8yrs |
Recent management updates
Recent updates
Some Investors May Be Willing To Look Past Takara Bio's (TSE:4974) Soft Earnings
May 22
Takara Bio (TSE:4974) Has Announced A Dividend Of ¥17.00
Mar 12Takara Bio (TSE:4974) Has Announced A Dividend Of ¥17.00
Feb 18Earnings Update: Takara Bio Inc. (TSE:4974) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts
Feb 16Takara Bio (TSE:4974) Has Affirmed Its Dividend Of ¥17.00
Jan 31Takara Bio (TSE:4974) Is Paying Out A Dividend Of ¥17.00
Jan 17Some May Be Optimistic About Takara Bio's (TSE:4974) Earnings
Nov 20Takara Bio (TSE:4974) Is Paying Out A Dividend Of ¥17.00
Nov 11CEO
Tsuyoshi Miyamura (62 yo)
Mr. Tsuyoshi Miyamura was Senior Managing Director & Director of Takara Bio Inc. from June 2023. Mr. Miyamura was Senior Managing Executive Officer & Director of Takara Bio Inc. from April 2022 to June 202...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 11.3yrs | no data | 0.011% ¥ 13.2m | |
| CFO, Senior Executive Officer & Director | 3.8yrs | no data | 0.014% ¥ 16.3m | |
| Managing Executive Officer & Head of Sales Division | 2.8yrs | no data | no data | |
| Executive Officer | no data | no data | no data | |
| VP, Executive Officer & Director | 3.8yrs | no data | 0.012% ¥ 13.7m | |
| CDXO, Executive Officer & Director | 8.3yrs | no data | 0.0070% ¥ 8.0m | |
| Head of Research and Development | no data | no data | no data | |
| Senior Executive Officer & Head of SCM Division | 2.8yrs | no data | no data | |
| Managing Executive Officer & Head of Quality Control Headquarters | 1.8yrs | no data | no data |
Experienced Management: 4974's management team is considered experienced (3.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 7.3yrs | no data | 0.011% ¥ 13.2m | |
| CFO, Senior Executive Officer & Director | 4.3yrs | no data | 0.014% ¥ 16.3m | |
| VP, Executive Officer & Director | 11.3yrs | no data | 0.012% ¥ 13.7m | |
| CDXO, Executive Officer & Director | 2.8yrs | no data | 0.0070% ¥ 8.0m | |
| Director | 3.3yrs | no data | 0.044% ¥ 50.2m | |
| Chairman | 23.5yrs | no data | 0.063% ¥ 72.5m | |
| Independent External Director | 6.3yrs | no data | no data | |
| Independent External Director | 9.3yrs | no data | no data | |
| Independent Outside Audit & Supervisory Board Member | 9.3yrs | no data | no data | |
| Independent Outside Audit & Supervisory Board Member | 9.3yrs | no data | no data | |
| Independent Outside Audit & Supervisory Board Member | 8.3yrs | no data | no data | |
| Independent External Director | 5.3yrs | no data | no data |
Experienced Board: 4974's board of directors are considered experienced (7.8 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/10/04 19:32 |
| End of Day Share Price | 2025/10/03 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2025/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Takara Bio Inc. is covered by 9 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Hidemaru Yamaguchi | Citigroup Inc |
| Yen Ting Chen | Credit Suisse |
| Kiyokazu Yamazaki | Ichiyoshi Research Institute Inc. |